Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer
Clinical trial NCT05673629 · UNKNOWN
Trial details
- NCT number
- NCT05673629
- Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-30
- Primary completion
- 2025-06-15
- Enrollment
- 552
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.